• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉痉挛和血管舒缩功能障碍是 MINOCA 的病因。

Coronary spasm and vasomotor dysfunction as a cause of MINOCA.

机构信息

Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

出版信息

EuroIntervention. 2024 Jan 15;20(2):e123-e134. doi: 10.4244/EIJ-D-23-00448.

DOI:10.4244/EIJ-D-23-00448
Abstract

Increasing evidence has shown that coronary spasm and vasomotor dysfunction may be the underlying cause in more than half of myocardial infarctions with non-obstructive coronary arteries (MINOCA) as well as an important cause of chronic chest pain in the outpatient setting. We review the contemporary understanding of coronary spasm and related vasomotor dysfunction of the coronary arteries, the pathophysiology and prognosis, and current and emerging approaches to diagnosis and evidence-based treatment.

摘要

越来越多的证据表明,冠状动脉痉挛和血管舒缩功能障碍可能是半数以上非阻塞性冠状动脉心肌梗死(MINOCA)的根本原因,也是门诊慢性胸痛的重要原因。我们回顾了对冠状动脉痉挛和相关冠状动脉血管舒缩功能障碍的现代认识,包括病理生理学和预后,以及目前和新兴的诊断方法和循证治疗。

相似文献

1
Coronary spasm and vasomotor dysfunction as a cause of MINOCA.冠状动脉痉挛和血管舒缩功能障碍是 MINOCA 的病因。
EuroIntervention. 2024 Jan 15;20(2):e123-e134. doi: 10.4244/EIJ-D-23-00448.
2
Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries.心肌缺血和非阻塞性冠状动脉患者心外膜和微血管痉挛的临床、血管造影和超声心动图相关性。
Clin Res Cardiol. 2020 Apr;109(4):435-443. doi: 10.1007/s00392-019-01523-w. Epub 2019 Jul 3.
3
Coronary artery spasm-induced acute myocardial infarction in patients with myocardial infarction with non-obstructive coronary arteries.非阻塞性冠状动脉心肌梗死患者中冠状动脉痉挛诱发的急性心肌梗死
Heart Vessels. 2021 Dec;36(12):1804-1810. doi: 10.1007/s00380-021-01878-z. Epub 2021 Jul 2.
4
The Significance of Recognizing Myocardial Bridge in the Coronary Spasm Diagnosis in Myocardial Infarction with Nonobstructive Coronary Arteries.认识心肌桥在非阻塞性冠状动脉心肌梗死冠状动脉痉挛诊断中的意义。
Intern Med. 2020 Jan 1;59(1):89-92. doi: 10.2169/internalmedicine.3266-19. Epub 2019 Sep 3.
5
Cardiac arrest in myocardial infarction with non-obstructive coronary artery (MINOCA) secondary to thyroid dysfunction.甲状腺功能异常继发非阻塞性冠状动脉心肌梗死导致的心脏骤停(MINOCA)。
BMJ Case Rep. 2023 Feb 10;16(2):e253500. doi: 10.1136/bcr-2022-253500.
6
Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA).非 ST 段抬高型心肌梗死无罪犯病变(MINOCA)中的微血管痉挛。
Clin Res Cardiol. 2020 Feb;109(2):246-254. doi: 10.1007/s00392-019-01507-w. Epub 2019 Jun 24.
7
Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non-Obstructive Coronary Arteries: Pathogenic and Prognostic Implications.心肌桥与非阻塞性冠状动脉疾病心肌缺血患者中冠状动脉痉挛的相互作用:发病机制和预后意义。
J Am Heart Assoc. 2021 Jul 20;10(14):e020535. doi: 10.1161/JAHA.120.020535. Epub 2021 Jul 14.
8
Air Pollution and Coronary Vasomotor Disorders in Patients With Myocardial Ischemia and Unobstructed Coronary Arteries.空气污染与无阻塞性冠状动脉病变的心肌缺血患者的冠状血管舒缩障碍。
J Am Coll Cardiol. 2022 Nov 8;80(19):1818-1828. doi: 10.1016/j.jacc.2022.08.744. Epub 2022 Aug 29.
9
Coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteries: Where do we stand?冠状动脉微血管功能障碍与非阻塞性冠状动脉心肌梗死:我们目前的进展如何?
Eur J Intern Med. 2023 Nov;117:8-20. doi: 10.1016/j.ejim.2023.07.016. Epub 2023 Jul 22.
10
Advances in Mechanisms and Treatment Options of MINOCA Caused by Vasospasm or Microcirculation Dysfunction.MINOCA 由血管痉挛或微循环功能障碍引起的发病机制和治疗选择的研究进展。
Curr Pharm Des. 2018;24(4):517-531. doi: 10.2174/1381612824666180108121253.

引用本文的文献

1
Myocardial Infarction in Young Adults: A Case Series and Comprehensive Review of Molecular and Clinical Mechanisms.年轻成年人的心肌梗死:病例系列及分子与临床机制的综合综述
Biomolecules. 2025 Jul 23;15(8):1065. doi: 10.3390/biom15081065.
2
Unveiling the Causes of Acute and Non-Acute Myocardial Ischemic Syndromes: The Role of Optical Coherence Tomography.揭示急性和非急性心肌缺血综合征的病因:光学相干断层扫描的作用
Medicina (Kaunas). 2025 Jul 4;61(7):1218. doi: 10.3390/medicina61071218.
3
Myocardial Infarction in the Young: Aetiology, Emerging Risk Factors, and the Role of Novel Biomarkers.

本文引用的文献

1
Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial.地尔硫䓬改善非冠状动脉粥样硬化性急性冠状动脉综合征患者冠状动脉血管运动功能障碍的疗效:EDIT-CMD 随机临床试验。
JACC Cardiovasc Imaging. 2022 Aug;15(8):1473-1484. doi: 10.1016/j.jcmg.2022.03.012. Epub 2022 Apr 2.
2
Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries.稳定型心肌缺血或心肌梗死伴非阻塞性冠状动脉患者乙酰胆碱试验的安全性和预后相关性。
EuroIntervention. 2022 Oct 7;18(8):e666-e676. doi: 10.4244/EIJ-D-21-00971.
3
青年人心肌梗死:病因、新出现的危险因素及新型生物标志物的作用
J Cardiovasc Dev Dis. 2025 Apr 10;12(4):148. doi: 10.3390/jcdd12040148.
4
Modulation of Abnormal Vasoconstriction Through 2-Hydroxyisobutyrylation of Tropomyosin 3 Lys141: Targeting Histone Deacetylase 3 as a Key Approach.通过原肌球蛋白3赖氨酸141的2-羟基异丁酰化调节异常血管收缩:以组蛋白去乙酰化酶3为关键靶点。
J Am Heart Assoc. 2025 Jan 7;14(1):e037400. doi: 10.1161/JAHA.124.037400. Epub 2024 Dec 24.
5
Physiology and functional significance of the coronary microcirculation: An overview of its implications in health and disease.冠状动脉微循环的生理学及功能意义:健康与疾病中的影响概述
Am Heart J Plus. 2024 Mar 8;40:100381. doi: 10.1016/j.ahjo.2024.100381. eCollection 2024 Apr.
Acetylcholine Rechallenge: A First Step Toward Tailored Treatment in Patients With Coronary Artery Spasm.
乙酰胆碱再挑战:冠状动脉痉挛患者个体化治疗的第一步。
JACC Cardiovasc Interv. 2022 Jan 10;15(1):65-75. doi: 10.1016/j.jcin.2021.10.003.
4
Angina due to coronary artery spasm (variant angina): diagnosis and intervention strategies.因冠状动脉痉挛(变异型心绞痛)导致的心绞痛:诊断和干预策略。
Expert Rev Cardiovasc Ther. 2021 Oct;19(10):917-927. doi: 10.1080/14779072.2021.1991314. Epub 2021 Oct 28.
5
Repurposing Riociguat for Treatment of Refractory Angina Resulting From Coronary Spasm.将利奥西呱重新用于治疗冠状动脉痉挛所致难治性心绞痛。
JACC Case Rep. 2021 Feb 24;3(3):392-396. doi: 10.1016/j.jaccas.2020.11.043. eCollection 2021 Mar.
6
Principles and pitfalls in coronary vasomotor function testing.冠状动脉血管舒缩功能检测的原则与陷阱。
EuroIntervention. 2022 Feb 18;17(15):1271-1280. doi: 10.4244/EIJ-D-21-00402.
7
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.欧洲心脏病学会与冠状动脉病理生理学和微循环工作组合作的 EAPCI 专家共识文件,缺血与非阻塞性冠状动脉,由冠状动脉血管舒缩障碍国际研究小组认可。
EuroIntervention. 2021 Jan 20;16(13):1049-1069. doi: 10.4244/EIJY20M07_01.
8
Diagnostic Approach to Patients with Stable Angina and No Obstructive Coronary Arteries.对稳定型心绞痛且无阻塞性冠状动脉疾病患者的诊断方法
Eur Cardiol. 2019 Jul 11;14(2):97-102. doi: 10.15420/ecr.2019.22.2. eCollection 2019 Jul.
9
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.当代非阻塞性冠状动脉疾病患者心肌梗死的诊断与管理:美国心脏协会科学声明。
Circulation. 2019 Apr 30;139(18):e891-e908. doi: 10.1161/CIR.0000000000000670.
10
Sympathectomy versus conventional treatment for refractory coronary artery spasm.交感神经切除术与传统治疗方法用于难治性冠状动脉痉挛的比较。
Coron Artery Dis. 2019 Sep;30(6):418-424. doi: 10.1097/MCA.0000000000000732.